1. RItA: The Italian severe/uncontrolled asthma registry
- Author
-
Maio, S., Baldacci, S., Bresciani, M., Simoni, M., Latorre, M., Murgia, N., Spinozzi, F., Braschi, M., Antonicelli, L., Brunetto, B., Iacovacci, P., Roazzi, P., Pini, C., Pata, M., La Grasta, L., Paggiaro, P., Viegi, G., Angino, A., Carrozzi, L., Cerrai, S., Di Pede, F., Martini, F., Pala, A. P., Pistelli, F., Sarno, G., Silvi, P., Novelli, F., Ferri, M., and Bonifazi, F.
- Subjects
Adult ,Male ,severe/uncontrolled asthma ,medicine.medical_specialty ,Exacerbation ,Immunology ,NO ,03 medical and health sciences ,0302 clinical medicine ,exacerbations ,pharmacological treatment ,Internal medicine ,eosinophilic inflammation ,medicine ,Humans ,Immunology and Allergy ,Nasal polyps ,Registries ,030212 general & internal medicine ,Sinusitis ,Aged ,Asthma ,business.industry ,Comorbidity ,Eosinophilic inflammation ,Exacerbations ,Pharmacological treatment ,Severe/uncontrolled asthma ,Emergency department ,Middle Aged ,medicine.disease ,Obesity ,Allergic conjunctivitis ,comorbidity ,Italy ,030228 respiratory system ,comorbidity, eosinophilic inflammation, exacerbations, pharmacological treatment, severe/uncontrolled asthma ,Physical therapy ,Female ,business - Abstract
Background The Italian severe/uncontrolled asthma (SUA) web-based registry encompasses demographic, clinical, functional, inflammatory data; it aims to raise SUA awareness, identifying specific phenotypes and promoting optimal care. Methods 493 adult patients from 27 Italian centres (recruited in 2011-2014) were analyzed. Results Mean age was 53.8yrs. SUA patients were more frequently female (60.6%), with allergic asthma (83.1%). About 30% showed late onset of asthma diagnosis/symptoms (>40yrs); the mean age for asthma symptoms onset was 30.2yrs and for asthma diagnosis 34.4yrs. 97.1% used ICS (dose 2000 BDP), 93.6% LABA in association with ICS, 53.3% LTRAs, 64.1% anti-IgE, 10.7% theophylline, 16.0% oral corticosteroids. Mean FEV1% pred of 75.1%, median values of 300/mm3 of blood eosinophil count, 323 kU/l of serum total IgE, 24 ppb of FENO were shown. Most common comorbidities were allergic rhinitis (62.4%), gastroesophageal reflux (42.1%), sinusitis (37.9%), nasal polyposis (30.2%), allergic conjunctivitis (30.2%). 55.7% of SUA patients had exacerbations in the last 12 months, 9.7% emergency department visits, 7.3% hospitalizations. Factors associated with exacerbation risk were: obesity (OR, 95%CI 2.46, 1.11-5.41), psychic disorders (2.87, 0.89-9.30 - borderline), nasal polyps (1.86, 0.88-3.89 - borderline), partial/poor asthma treatment adherence (2.54, 0.97-6.67 - borderline), anti-IgE use in a protective way (0.26, 0.12-0.53). Comparisons to severe asthma multicentre studies and available registries showed data consistency across European and American populations. Conclusions An international effort in the implementation of SUA patients registries could help to better understand the clinical features and to manage severe asthma, representing a non negligible socio-economic burden for health services. This article is protected by copyright. All rights reserved.
- Published
- 2017